Breaking News Instant updates and real-time market news.

ORCL

Oracle

$48.75

-4.04 (-7.65%)

, EFX

Equifax

$92.93

-3.735 (-3.86%)

16:15
09/15/17
09/15
16:15
09/15/17
16:15

On The Fly: Top stock stories for Friday

Stocks opened mixed but before long all three of the major equity averages were in positive territory. The early weakness followed the report of another missile firing by North Korea, a terrorist bombing in London, and weaker than expected data on retail sales and industrial production in the U.S. The averages hung onto their gains, capping a winning weak. Meanwhile, oil prices drifted for most of the day and closed a few pennies shy of the $50 dollar a barrel level. ECONOMIC EVENTS: In the U.S., industrial production fell 0.9% with capacity utilization at 76.1% in August. Those are weaker than expected, but the Fed said Hurricane Harvey reduced IP by about 0.75%. retail sales fell 0.2% in August, with the ex-auto component up 0.2%. Retail sales fell 0.2% in August, versus expectations for them to have risen 0.1%. Excluding cars, sales rose 0.2%, which was less than the 0.5% consensus forecast. The Empire State manufacturing survey headline reading fell slightly in September to 24.4 from a 3-year high of 25.2 in August. The University of Michigan said its consumer-sentiment index dropped to 95.3 in its preliminary September reading, down from the final August reading of 96.8. In energy news, Baker Hughes reported that the U.S. rig count is down 8 rigs from last week to 936. COMPANY NEWS: Shares of Oracle (ORCL) slipped 7.8% after the company reported quarterly results that were widely called "solid" by analysts, but issued constant currency guidance for the new quarter that missed estimates... Meanwhile, Equifax (EFX) has continued to experience mounting troubles associated with the massive data breach it disclosed last week. The company's European division today said that about 400,000 European customers have been hacked as well, while in the U.S. a group of Attorneys General issued a letter to Equifax's attorney requesting that the company stop selling credit monitoring services until the sign-up period for the free credit monitoring service has ended. Shares of Equifax continued their slide, falling an additional 3.74% today. MAJOR MOVERS: Among the noteworthy gainers was Abeona Therapeutics (ABEO), which surged 22.86% higher after the stock was initiated with an Outperform rating at RBC Capital. Also higher was Resolute Energy (REN), which gained 9.2% after it agreed to sell its subsidiary that holds interest in Aneth Field to an affiliate of Elk Petroleum for a total potential consideration of $195M. Among the notable losers was BioTelemetry (BEAT), which fell 11.86% after Off Wall Street initiated coverage of the stock with a Sell rating and $21 price target. Also lower was Acuity Brands (AYI), which slid 4.2% after an analyst from Wells Fargo downgraded the stock to Market Perform from Outperform. INDEXES: The Dow rose 64.86, or 0.29%, to 22,268.34, the Nasdaq gained 19.38, or 0.3%, to 6,448.47, and the S&P 500 advanced 4.61, or 0.18%, to 2,500.23.

ORCL

Oracle

$48.75

-4.04 (-7.65%)

EFX

Equifax

$92.93

-3.735 (-3.86%)

ABEO

Abeona Therapeutics

$17.20

3.2 (22.86%)

REN

Resolute Energy

$30.08

2.505 (9.09%)

BEAT

BioTelemetry

$32.70

-4.4 (-11.86%)

AYI

Acuity Brands

$170.55

-7.44 (-4.18%)

  • 19

    Sep

  • 25

    Sep

ORCL Oracle
$48.75

-4.04 (-7.65%)

09/15/17
UBSW
09/15/17
NO CHANGE
Target $57
UBSW
Buy
Oracle price target raised to $57 from $52 at UBS
UBS analyst Fatima Boolani raised her price target on Oracle to $57 from $52 following good Q1 results in what is normally a slow quarter. The analyst noted Q2 has tougher comps, causing the guidance to be somewhat mixed. Boolani reiterated her Buy rating on Oracle shares.
09/15/17
JMPS
09/15/17
NO CHANGE
JMPS
Market Perform
JMP says Oracle Q2 guidance suggests prior cloud assumptions too optimistic
JMP Securities analyst Patrick Walravens said Oracle reported "solid" Q1 results, but he blames the afterhours slide in the stock to high expectations coming into the call and constant currency guidance that missed estimates. The analyst, who said the Q2 guidance suggests that his prior cloud growth assumptions were too optimistic, keeps a Market Perform rating on Oracle shares, which are down over 4% to $50.55 in pre-market trading.
09/15/17
ADAM
09/15/17
NO CHANGE
Target $57
ADAM
Buy
Oracle key metrics better than expected, says Canaccord
Canaccord analyst Richard Davis said Oracle posted its third consecutive positive quarterly surprise, with most of the key metrics at least a little better than expected. He said his view remains unchanged and that the stock will outperform in down or choppy markets. Davis reiterated his Buy rating and raised his price target to $57 from $56 on Oracle shares.
09/15/17
MUFG
09/15/17
NO CHANGE
Target $61
MUFG
Overweight
Oracle should be bought on post-earnings weakness, says MUFG
MUFG analyst Stephen Bersey earlier today lowered his price target for Oracle shares to $61 from $63 but reiterated an Overweight rating on the name. The company last night posted a "solid" quarter as it continues its transition to the cloud, Bersey told investors in a research note. Oracle sustained 50%-plus year-over-year cloud revenue growth rates even as cloud revenue passed $1B in Q2 of FY17, Bersey noted. He recommends building or adding to positions on the post-earnings share weakness.
EFX Equifax
$92.93

-3.735 (-3.86%)

09/15/17
BARD
09/15/17
NO CHANGE
Target $115
BARD
Outperform
Equifax price target lowered to $115 from $141 at Baird
Baird analyst Jeffrey Mueler lowered his price target on Equifax to $115 from $141 as he reduced his Global Consumer revenue estimate while assuming tougher U.S. B2B new sales and cross-sales and some volume share loss. He is also assuming increased expenses and removing share repurchases from his estimates. Mueler maintained his Outperform rating on Equifax shares.
09/15/17
ARGS
09/15/17
DOWNGRADE
ARGS
Hold
Equifax downgraded to Hold from Buy at Argus
Argus analyst Jasper Hellweg downgraded Equifax to Hold following news of a major hack on the company's data that could have lasting effects. Hellweg does not believe the company has handled the aftermath of the breach very well and notes more than two dozen class-action lawsuits have been filed against Equifax and members of Congress have called for additional regulation of the credit reporting industry.
09/15/17
09/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Equifax (EFX) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg citing news of a major hack on the company's data that could have lasting effects. 2. FedEx (FDX) downgraded to Neutral from Buy at UBS with analyst Thomas Wadewitz citing TNT issues following the cyber-attack in June that knocked out multiple systems. 3. Carnival (CCL) downgraded to Neutral from Outperform at Credit Suisse with analyst Tim Ramskil saying he is worried that his estimate of absolute industry capacity growth in 2018-2021 is double that of the last five years. 4. American Airlines (AAL), United Continental (UAL), and Spirit Airlines (SAVE) were downgraded to Neutral from Overweight at JPMorgan. 5. Acuity Brands (AYI) downgraded to Market Perform from Outperform at Wells Fargo with analyst Richard Kwas saying his firm's electrical channel checks indicate the 8% consensus organic revenue growth estimate for FY18 does not have upside. The analyst thinks shares are likely range-bound in the $160-$200 range "for the time being." He believes a "material step up" in tiered solutions growth is needed for gross margin to outperform expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/15/17
09/15/17
NO CHANGE

SunTrust lowers Equifax, TransUnion price targets but advises buying stocks
SunTrust analyst Andrew Jeffrey cut his price target on Equifax (EFX) to $110 from $155 and lowered his price target on TransUnion (TRU) to $48 from $54. As reasons for the reductions, he cited increased competition from free credit monitoring programs and the risk of share loss in the wake of the Equifax data breach. However, he believes that both stocks reflect an "overstated" risk of negative legislative and/or regulatory changes. Jeffrey does not expect governments to create "barriers to complete and comprehensive data access," since, according to the analyst, lenders and many service providers rely on the data generated by the credit bureaus. He recommends buying both stocks.
ABEO Abeona Therapeutics
$17.20

3.2 (22.86%)

09/14/17
RBCM
09/14/17
INITIATION
Target $23
RBCM
Outperform
Abeona Therapeutics initiated with an Outperform at RBC Capital
RBC Capital analyst Matthew Eckler started Abeona Therapeutics with an Outperform rating and $23 price target.
07/19/17
MAXM
07/19/17
NO CHANGE
Target $17
MAXM
Buy
Abeona Therapeutics price target raised to $17 from $14 at Maxim
Maxim analyst Jason McCarthy noted that Abeona Therapeutics announced FDA guidance for accelerating EB-101 into a Phase 3 pivotal program in epidermolysis bullosa and that the gene therapy corrected skin grafts have demonstrated proof of concept data in the early going of a Phase 1/2 study in Recessive Dystrophic Epidermolysis Bullosa patients. Factoring in the potential for a RDEB indication for EB-101, McCarthy raised his price target on Abeona to $17 from $14 and keeps a Buy rating on the stock.
03/06/17
03/06/17
NO CHANGE

FBR sees 'prime' merger environment for biotechs under Trump
Potential tax reform and FDA policy changes under President Trump could "prime the pump" for acquisitions of clinical-stage biotech companies by Big Pharma, FBR Capital analysts led by Chris Meekins tell investors in a research note. These police moves, coupled with the repeal of some taxes associated with the Affordable Care Act, are likely to increase funds for companies looking to make acquisitions, the analysts contend. Within its coverage universe, FBR sees TESARO (TSRO), Agile Therapeutics (AGRX), Kite Pharma (KITE), Juno Therapeutics (JUNO), Acceleron Pharma (XLRN), Abeona Therapeutics (ABEO), Aurinia Pharmaceuticals (AUPH), Geron (GERN) and Genocea Biosciences (GNCA) as "primary targets for those looking to make acquisitions."
01/06/17
JEFF
01/06/17
INITIATION
Target $11
JEFF
Buy
Abeona Therapeutics initiated with a Buy at Jefferies
Jefferies analyst Gena Wang started Abeona Therapeutics with a Buy rating and $11 price target. The analyst sees a favorable risk/reward ahead of data readouts in the first half of 2017.
REN Resolute Energy
$30.08

2.505 (9.09%)

07/17/17
GSCO
07/17/17
INITIATION
Target $32
GSCO
Neutral
Resolute Energy initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Jon Nelson started Resolute Energy with a Neutral rating and $32 price target. The analyst believes the bull case for shares is being constrained by funding uncertainty.
09/15/17
KLRG
09/15/17
NO CHANGE
KLRG
Resolute Energy price target raised to $64 from $60 at KLR Group
KLR Group analyst John Gerdes maintained his Buy rating and raised his price target on Resolute Energy to $64 from $60, based on the company's accretive divestiture of its non-core Aneth field in the Paradox Basin of southeast Utah.
06/01/17
06/01/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pentair (PNR) reinstated with a Sell at Goldman Sachs. 2. Global Payments (GPN) coverage resumed with a Buy at Stifel. 3. Caesars (CZR) initiated with an Outperform at Oppenheimer. 4. Resolute Energy (REN) initiated with a Buy at SunTrust. 5. Ziopharm (ZIOP) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/17
IMPC
07/18/17
INITIATION
Target $40
IMPC
Outperform
Resolute Energy initiated with an Outperform at Imperial Capital
Imperial Capital analyst Jason Wangler started Resolute Energy with an Outperform rating and $40 price target.
BEAT BioTelemetry
$32.70

-4.4 (-11.86%)

12/02/16
DOTC
12/02/16
INITIATION
Target $26
DOTC
Buy
BioTelemetry initiated with a Buy at Dougherty
Dougherty analyst Gene Mannheimer initiated BioTelemetry with a Buy and a $26 price target.
09/15/17
BNCH
09/15/17
NO CHANGE
Target $44
BNCH
Buy
Benchmark says BioTelemetry has big head start over iRhythm
Following Off Wall Street's Sell rating on BioTelemetry, Benchmark analyst Bill Sutherland says recent discussions with management has raised no "red flags" about the outlook for the company's legacy business. In an email to investors, the analyst notes that BioTelemetry has a large head start over competitor iRhythm (IRTC), which Off Wall Street references in its short report. He adds that the holter monitor segment, while large, is not BioTelemetry's focus. Sutherland has a Buy rating on the shares with a $44 price target. BioTelemetry is down 11%, or $4.15, to $32.95 in afternoon trading.
07/14/17
LSCM
07/14/17
NO CHANGE
Target $50
LSCM
Buy
BioTelemetry price target raised to $50 from $35 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for BioTelemetry to $50 saying the recently closed LifeWatch acquisition should drive profitable growth and position the arrhythmia monitoring platform for expansion. The analyst believes investors should buy the stock now, before the Q2 results. He reiterates a Buy rating on the name.
AYI Acuity Brands
$170.55

-7.44 (-4.18%)

09/14/17
WELS
09/14/17
DOWNGRADE
WELS
Market Perform
Acuity Brands downgraded to Market Perform from Outperform at Wells Fargo
06/06/17
WELS
06/06/17
NO CHANGE
Target $200
WELS
Outperform
Acuity Brands rises after Wells Fargo signals better demand
Shares of Acuity Brands are rising in early trading after Wells Fargo analyst Richard Kwas reported in a pre-open note to investors that the firm's channel checks revealed that agents and distributors are seeing better year-over-year growth in the second quarter than they did in the first three months of the year. Ahead of the company's earnings report on June 29, Kwas contends that the consensus revenue forecast "looks beatable" and he raised his price target on Acuity to $200 from $196. Kwas maintains an Outperform rating on the stock, which is up $3.85, or 2.3%, to $172.01 in morning trading.
09/15/17
WELS
09/15/17
DOWNGRADE
WELS
Market Perform
Acuity Brands downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Richard Kwas downgraded Acuity Brands to Market Perform saying his firm's electrical channel checks indicate the 8% consensus organic revenue growth estimate for FY18 does not have upside. The analyst thinks shares are likely range-bound in the $160-$200 range "for the time being." He believes a "material step up" in tiered solutions growth is needed for gross margin to outperform expectations.

TODAY'S FREE FLY STORIES

NTAP

NetApp

$63.59

1.32 (2.12%)

12:55
01/18/18
01/18
12:55
01/18/18
12:55
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

VCEL

Vericel

$6.55

0.3 (4.80%)

12:46
01/18/18
01/18
12:46
01/18/18
12:46
Hot Stocks
RTW Invesmtents reports 5.04% passive stake in Vericel »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

DDAIF

Daimler AG

$90.67

0.17 (0.19%)

12:45
01/18/18
01/18
12:45
01/18/18
12:45
Periodicals
Daimler, Bosch suffer walkouts in industrial labor dispute, Reuters says »

Approximately 44,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$15.78

0.71 (4.71%)

12:45
01/18/18
01/18
12:45
01/18/18
12:45
Options
Amicus call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$113.44

0.45 (0.40%)

12:41
01/18/18
01/18
12:41
01/18/18
12:41
Periodicals
JPMorgan sued for over $875M by Nigeria over 2011 oilfield deal, Reuters reports »

JPMorgan has been sued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

FSNN

Fusion Telecommunications

$3.83

-0.03 (-0.78%)

12:33
01/18/18
01/18
12:33
01/18/18
12:33
Hot Stocks
Cooper Creek Partners reports 5.17% passive stake in Fusion Telecommunications »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

, MS

Morgan Stanley

$55.59

0.235 (0.42%)

12:29
01/18/18
01/18
12:29
01/18/18
12:29
General news
On The Fly: Top stock stories at midday »

Stock futures were above…

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

MS

Morgan Stanley

$55.59

0.235 (0.42%)

LGF.A

Lionsgate

$34.99

2.71 (8.40%)

CBS

CBS

$61.09

2.19 (3.72%)

VIAB

Viacom

$31.96

0.58 (1.85%)

VIA

Viacom

$37.85

0.95 (2.57%)

GNC

GNC Holdings

$4.95

1.48 (42.65%)

PTC

PTC

$66.70

1.41 (2.16%)

AA

Alcoa

$52.37

-4.6199 (-8.11%)

ENDP

Endo

$7.69

-0.32 (-4.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 18

    Mar

IP

International Paper

$62.23

0.74 (1.20%)

12:25
01/18/18
01/18
12:25
01/18/18
12:25
Options
International Paper call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

FMC

FMC Corporation

$88.41

-5.45 (-5.81%)

12:23
01/18/18
01/18
12:23
01/18/18
12:23
Recommendations
FMC Corporation analyst commentary  »

FMC Corporation pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 07

    Mar

BBBY

Bed Bath & Beyond

$23.40

0.39 (1.69%)

12:21
01/18/18
01/18
12:21
01/18/18
12:21
Hot Stocks
Bed Bath & Beyond recalls Hudson Comforters on mold exposure 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLB

Columbia Banking

$45.94

0.36 (0.79%)

12:19
01/18/18
01/18
12:19
01/18/18
12:19
Hot Stocks
Columbia Bank names Lisa Dow chief risk officer »

Columbia Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ACOR

Acorda Therapeutics

$24.75

-0.3 (-1.20%)

12:17
01/18/18
01/18
12:17
01/18/18
12:17
Periodicals
Acorda Therapeutics jumps after web report about takeover approach »

According to a report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
01/18/18
01/18
12:17
01/18/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/18/18
01/18
12:16
01/18/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
01/18/18
01/18
12:15
01/18/18
12:15
General news
Atlanta Fed's Q4 GDPNow estimate was raised to 3.4%: »

Atlanta Fed's Q4…

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

, SNE

Sony

$49.18

-0.6438 (-1.29%)

12:12
01/18/18
01/18
12:12
01/18/18
12:12
Periodicals
Amazon looks to compete in commercial films, less indies, Reuters says »

Amazon (AMZN) is looking…

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

SNE

Sony

$49.18

-0.6438 (-1.29%)

FOX

21st Century Fox

$36.49

0.7 (1.96%)

TWX

Time Warner

$92.31

0.14 (0.15%)

VIA

Viacom

$37.85

0.95 (2.57%)

CMCSA

Comcast

$41.68

-0.14 (-0.33%)

DIS

Disney

$111.33

-0.64 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 18

    Mar

MELI

MercadoLibre

$340.45

0.6 (0.18%)

12:10
01/18/18
01/18
12:10
01/18/18
12:10
Options
$45.5M option print in MercadoLibre »

$45.5M option print in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$87.26

-6.6001 (-7.03%)

, SQM

SQM

$57.76

-1.79 (-3.01%)

12:06
01/18/18
01/18
12:06
01/18/18
12:06
Recommendations
FMC Corporation, SQM analyst commentary  »

FMC Corporation selloff…

FMC

FMC Corporation

$87.26

-6.6001 (-7.03%)

SQM

SQM

$57.76

-1.79 (-3.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 07

    Mar

AXP

American Express

$100.20

-0.56 (-0.56%)

, V

Visa

$122.37

0.39 (0.32%)

12:06
01/18/18
01/18
12:06
01/18/18
12:06
Earnings
On The Fly: What to watch in credit card space earnings reports »

American Express (AXP) is…

AXP

American Express

$100.20

-0.56 (-0.56%)

V

Visa

$122.37

0.39 (0.32%)

MA

MasterCard

$164.92

0.6 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 01

    Feb

  • 01

    Feb

DIS

Disney

$111.22

-0.75 (-0.67%)

12:03
01/18/18
01/18
12:03
01/18/18
12:03
Hot Stocks
Disney, Twitch announce multi-year content partnership »

Social video service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 06

    Feb

INTC

Intel

$44.39

1.25 (2.90%)

12:01
01/18/18
01/18
12:01
01/18/18
12:01
Hot Stocks
Intel debuts technologies, including RealSense Volumetric Content Capture »

During the 2018 Sundance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

FMC

FMC Corporation

$87.26

-6.6 (-7.03%)

, SQM

SQM

$57.49

-2.065 (-3.47%)

12:00
01/18/18
01/18
12:00
01/18/18
12:00
Recommendations
FMC Corporation, SQM analyst commentary  »

FMC Corporation pullback…

FMC

FMC Corporation

$87.26

-6.6 (-7.03%)

SQM

SQM

$57.49

-2.065 (-3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 07

    Mar

SBAC

SBA Communications

$161.47

1.62 (1.01%)

12:00
01/18/18
01/18
12:00
01/18/18
12:00
Options
One-day put sellers in SBA Comm »

One-day put sellers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$33.90

1.62 (5.02%)

, CBS

CBS

$61.09

2.19 (3.72%)

11:58
01/18/18
01/18
11:58
01/18/18
11:58
Hot Stocks
Lionsgate jumps after report on potential takeover interest »

Shares of Lionsgate…

LGF.A

Lionsgate

$33.90

1.62 (5.02%)

CBS

CBS

$61.09

2.19 (3.72%)

VIAB

Viacom

$31.96

0.58 (1.85%)

VIA

Viacom

$37.85

0.95 (2.57%)

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

VZ

Verizon

$52.78

1.055 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 23

    Jan

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 18

    Mar

ADP

ADP

$122.05

2.66 (2.23%)

, CSOD

Cornerstone OnDemand

$39.28

0.34 (0.87%)

11:52
01/18/18
01/18
11:52
01/18/18
11:52
Conference/Events
Stephens enterprise software analyst holds analyst/industry conference call »

Enterprise Software…

ADP

ADP

$122.05

2.66 (2.23%)

CSOD

Cornerstone OnDemand

$39.28

0.34 (0.87%)

MSFT

Microsoft

$90.14

1.79 (2.03%)

ORCL

Oracle

$50.26

-0.01 (-0.02%)

PAYC

Paycom

$88.34

-0.01 (-0.01%)

PCTY

Paylocity

$49.46

0.71 (1.46%)

SAP

SAP

$111.45

0.2601 (0.23%)

ULTI

Ultimate Software

$226.26

3.48 (1.56%)

WDAY

Workday

$112.26

2.17 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 22

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 13

    Feb

  • 26

    Feb

  • 13

    Mar

  • 14

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.